Yesterday, the Judicial Panel on Multidistrict Litigation (JPML) created a new MDL for federal lawsuits for individuals who have developed a serious vision disorder called pigmentary maculopathy after taking Elmiron®. The lawsuits allege that the drugmakers failed to properly warn consumers, physicians, and the public that Elmiron® could cause significant visual damage, including atypical or pigmentary...